Sign In   |   Register
News: Congress

News and views from EAS 2019 Maastricht: Video interviews Late breaking session on Monday

Tuesday 28 May 2019   (0 Comments)
Share |

Dr. Antonio J. Vallejo-Vaz (Imperial College, London,UK) discusses a post hoc analysis of the 4S trial focusing on patients with a likely genetic vulnerability to high cholesterol – ‘FH phenotype’

Professor Derick Raal (University of the Witwatersrand, Johannesburg, South Africa) discusses ORION-2, a proof-of concept study with the siRNA inclisiran in homozygous familial hypercholesterolemia

Professor Evan Stein ((LIB Therapeutics and Metabolic & Atherosclerosis Research Center, Cincinnati, USA) discusses findings from a phase 2 trial with LIB003, a novel agent targeting PCSK9

Dr. Christie Ballantyne (Baylor College of Medicine, Houston, Texas, USA) discusses a trial with the fixed combination of bempedoic acid and ezetimibe in high risk patients not at LDL-C goal.

Membership Software Powered by YourMembership  ::  Legal